Fluvoxamine Mediates Specific, Early, and Delayed SARS-CoV-2 Protection through Antioxidant and Cytoprotective Pathways via Sigma-1 Receptor Agonism
Adv Pharm Bull
.
2023 Jul;13(3):408-410.
doi: 10.34172/apb.2023.045.
Epub 2022 Sep 18.
Authors
Konstantinos Papadopoulos
1
,
Alexandra Papadopoulou
2
,
Tar Choon Aw
3
Affiliations
1
THAI StemLife, 566/3 Soi Ramkhamhaeng 39 (Thepleela 1), Prachaouthit Rd., Wangthonglang, Wangthonglang, Bangkok 10310, Thailand.
2
Occupational and Environmental Health Services, Feelgood Lund, Ideon Science Park, Scheelevägen 17, 223 63 Lund, Sweden.
3
Department of Laboratory Medicine, Changi General Hospital, 2 Simei Street 3, Singapore 529889.
PMID:
37646061
PMCID:
PMC10460798
DOI:
10.34172/apb.2023.045
No abstract available